Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine (Ebixa) for functional disability in amyotrophic lateral sclerosis
2007-002117-39Phase 2Active
- Sponsor
- Jorge Matias-Guiu Guia
- Start
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of memantine in amyotrophic lateral sclerosis (ALS), sponsored by Jorge Matias-Guiu Guia. Primary endpoints: Functional disability progression and Safety of memantine. Started Feb 2008; status: active.
02
Drugs
memantine
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on 2007-002117-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002117-39.